| __timestamp | Bio-Techne Corporation | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 242549000 |
| Thursday, January 1, 2015 | 40853000 | 245098000 |
| Friday, January 1, 2016 | 45187000 | 147600000 |
| Sunday, January 1, 2017 | 53514000 | 264600000 |
| Monday, January 1, 2018 | 55329000 | 357900000 |
| Tuesday, January 1, 2019 | 62413000 | 1182600000 |
| Wednesday, January 1, 2020 | 65192000 | 357700000 |
| Friday, January 1, 2021 | 70603000 | 540100000 |
| Saturday, January 1, 2022 | 87140000 | 322900000 |
| Sunday, January 1, 2023 | 92493000 | 408000000 |
| Monday, January 1, 2024 | 96664000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) expenses are a key indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Bio-Techne Corporation have demonstrated contrasting strategies in their R&D investments.
United Therapeutics, a leader in the field, has consistently outpaced Bio-Techne in R&D spending. In 2019, United Therapeutics reached a peak, investing nearly four times more than Bio-Techne. However, their spending has shown volatility, with a significant dip in 2016. In contrast, Bio-Techne has steadily increased its R&D budget, growing by approximately 213% from 2014 to 2024.
This trend highlights United Therapeutics' aggressive yet fluctuating approach, while Bio-Techne's consistent growth strategy reflects a more stable investment in innovation. As we look to the future, these spending patterns may offer insights into each company's potential for groundbreaking advancements.
Analyzing R&D Budgets: Sanofi vs United Therapeutics Corporation
Gilead Sciences, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Bio-Techne Corporation
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Breaking Down Revenue Trends: United Therapeutics Corporation vs Bio-Techne Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
United Therapeutics Corporation or Vericel Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Spending Showdown: Bio-Techne Corporation vs Ultragenyx Pharmaceutical Inc.